
Βk-2C-B
Βk-2C-B | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chemical Nomenclature | |||||||||||||||||||||||||||||||||
Common names | Methallylescaline, MAL | ||||||||||||||||||||||||||||||||
Substitutive name | 4-methallyloxy-3,5-dimethoxyphenethylamine | ||||||||||||||||||||||||||||||||
Systematic name | 2-(3,5-dimethoxy-4-[(2-methylprop-2-en-1-yl)oxy]phenyl)ethanamine | ||||||||||||||||||||||||||||||||
Class Membership | |||||||||||||||||||||||||||||||||
Psychoactive class | Psychedelic | ||||||||||||||||||||||||||||||||
Chemical class | Phenethylamine | ||||||||||||||||||||||||||||||||
Routes of Administration | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Interactions | |||||||||||||||||||||||||||||||||
BK-2C-B, βk-2C-B or beta-keto 2C-B is a psychedelic drug and entheogen of the phenethylamine class of compounds. It is structurally related to 2C-B and BOB. This compound is relatively uncommon and has little to no history of human usage prior to its 2014 sale as a research chemical by online vendors. Very little data exists about the pharmacological properties, metabolism, and toxicity of BK-2C-B.
The effects of this compound were first described by Alexander Shulgin in his book PiHKAL: A Chemical Love Story. He lists the dosage range as 40mg to 60mg orally and describes the duration of action to be 8 - 12 hours.[1]
Chemistry
This chemistry section is incomplete. You can help by adding to it. |
Pharmacology
Methallylescaline acts as a 5-HT2A partial agonist. The psychedelic effects are believed to come from methallylescaline's efficacy at the 5-HT2A receptors. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.
Subjective effects
![]() |
This subjective effects section is a stub. As such, it is still in progress and may contain incomplete or wrong information. You can help by expanding or correcting it. |
The effects listed below are based upon the subjective effects index and personal experiences of PsychonautWiki contributors. The listed effects will rarely (if ever) occur all at once, but heavier dosages will increase the chances and are more likely to induce a full range of effects.
Physical effects
- Spontaneous tactile sensations
- Stimulation
- Nausea
- Tactile enhancement
- Bodily control enhancement
- Pupil dilation
- Wakefulness
Cognitive effects
- Current mind state enhancement
- Thought acceleration
- Novelty enhancement
- Time distortion
- Analysis enhancement
- Personal bias suppression
- Conceptual thinking
- Immersion enhancement
- Memory suppression
- Thought loops
- Delusions
- Thought disorganization
Visual effects
Enhancements
Distortions
- Drifting (melting, flowing, breathing and morphing)
- Tracers
- After images
- Symmetrical texture repetition
- Colour shifting
- Scenery slicing
Hallucinatory states
- Transformations
- Internal hallucinations (autonomous entities; settings, sceneries, and landscapes; alterations in perspective and scenarios and plots)
Auditory effects
Toxicity and harm potential
Lethal dosage
The toxicity and long-term health effects of recreational methallylescaline use do not seem to have been studied in any scientific context and the median lethal dose (LD50) is unknown. This is because methallylescaline is a research chemical with very little history of human usage. Anecdotal evidence from those who have used escaline would suggest that there are little to no immediate or short-term negative health effects attributed to simply trying the drug at low to moderate doses or using it very sparingly. The validity of these statements, however, cannot be confirmed.
Tolerance and addiction potential
The addictive potential of methallylescaline has not yet been formally studied, but anecdotal evidence would suggest that methallylescaline is not physically addictive. Many users describe a self-regulating quality and commonly report a tolerance build up when using the drug consecutively many days in a row. A build up in tolerance may lead to weakened effects and a diminished experience, however, this effect is nearly non-existent when consumption periods are spaced 5-7 days apart.
Legal issues
![]() |
This legality section is a stub. As such, it may contain incomplete or wrong information. You can help by expanding it. |
- United States: Methallylescaline is unscheduled in the U.S., but may be illegal via the Federal Analog Act.
See also
External links
- Escaline (PiHKAL)
- Methallylescaline (Wikipedia)
- Methallylescaline experiences (Erowid)
- Methallylescaline (Tripsit)
- Methallylescaline (Bluelight)
References
- ↑ www.erowid.org/library/books_online/pihkal/pihkal072.shtml | #72 E; ESCALINE